ICH GCP Guidelines E6 Revision, R2 Addendum – Changes Impacting Sponsors-CRO-Sites
January 15, 2019 - Online Event ON CAWebinar Compliance
info@webinarcompliance.com
Phone:1-416-915-4458
The revised guidelines are entitled “Integrated Addendum To ICH E6(R1): Guideline For Good Clinical Practice E6(R2).” The ICH steering committee comprised of representatives from the pharmaceutical industry and the regulatory bodies of the United States, Japan, the European Union (EU), Canada, and Switzerland. In this webinar we will identify the changes impacting investigators, sites, Sponsors, CROs: responsibilities and roles and explain the impact of the revisions on clinical trials conduct and organizational practices.
This website uses cookies to ensure you get the best experience on our website. Learn more